Xenon Pharmaceuticals Inc. (XENE) NASDAQ
52.30
-1.11(-2.08%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
52.30
-1.11(-2.08%)
Currency In USD
| Market Cap | 3.55B |
| Enterprise Value | 3.36B |
| P/E Ratio | -11.92 |
| PEG Ratio | 0.35 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.41 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -9 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.28 |
| Return On Equity | -0.49 |
| Revenue | 7.5M |
| Revenue/Share | 0 |
| Gross Profit | 4.96M |
| EBITDA | -342.35M |
| Net Income | -345.91M |
| Diluted EPS | -4.36 |
| Total Cash | 1.09B |
| Total Cash/Share | 12.53 |
| Total Debt | 7.49M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 27.79 |
| Book Value Per Share | 15.32 |
| 52-Week Change | 73.93 |
| 52-Week High | 63.95 |
| 52-Week Low | 29.74 |
| Moving Average 50 Days | 56.04 |
| Moving Average 200 Days | 45.54 |
| Average Volume | 1.47M |
| Shares Outstanding | 78.95M |
| % Held by Institutions | 126.46 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |